Sort
82,697 grants matching “vaccine development”
Molecularly Targeted Vaccines for Anthrax
$1,010,854Kemp Bailey Cease · University Of Michigan At Ann Arbor · U01 · FY2007 · AI
Role of inflammation, innate resistance, and immunity in carcinogenesis
$1,010,680Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
FOOD AND WATERBORNE DISEASES INTEGRATED RESEARCH NETWORKS
$1,010,653Carole Tacket · University Of Maryland Baltimore · N01 · FY2009 · AI
Experimental characterization of the dynamics of immune responses to influenza
$1,010,549Rafi Ahmed · Emory University · U19 · FY2017 · AI
Shigella Conjugate Vaccine (SCV4) Development, Characterization, and Pre-clinical Evaluation
$1,010,389Edward T. Ryan · Massachusetts General Hospital · R01 · FY2023 · AI
Technologies to Advance Next Generation Anthrax Vaccines
$1,010,295Howard Tranrer · Uk Health Security Agency · N01 · FY2015 · AI
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
$1,010,181Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2018 · AI
Development
$1,010,066Ana M Navarro · University Of California, San Diego · U54 · FY2010 · CA
Human Papillomavirus and Polyomavirus Associated Malignancies.
$1,010,057Denise A. Galloway · Fred Hutchinson Cancer Center · R35 · FY2023 · CA
Antibody immunotherapeutics for biodefense against Lassa virus
$1,010,001Robert F Garry · Tulane University Of Louisiana · R01 · FY2015 · AI
Therapeutic and Diagnostic Antibodies Against SARS
$1,009,959Diversa Corporation · U01 · FY2004 · AI
Development Of New Approaches To Vaccines Against TBEV and West Nile Virus
$1,009,924Alexander Pletnev · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Sample Collection and General Screening Protocols
$1,009,733Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Los Angeles Pediatric AIDS Clinical Trials Unit
$1,009,613University Of California Los Angeles · U01 · FY2003 · AI
Point-of-care lateral flow immunoassay for diagnosis of pertussis
$1,009,408Amanda Burnham-Marusich · Dxdiscovery, Inc. · R44 · FY2023 · AI
Vaccine Studies of Simian Immunodeficiency Virus (SIV) in Macaques
$1,009,235Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
A Novel Live Non-replicating Universal Vaccine for Influenza
$1,009,220Sally R. Sarawar · Biomedical Research Instit/ Southern, Ca · R01 · FY2014 · AI
Clinical Subjects and Biospecimen Core
$1,009,218Nirav Rati Bhakta · University Of California, San Francisco · U19 · FY2021 · AI
Pathogenesis Studies Of Simian Immunodeficiency Virus Infection Of Monkeys
$1,009,129Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Vaccine Studies of Simian Immunodeficiency Virus (SIV) in Macaques
$1,009,129Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Autoimmunity: Mechanisms of Unresponsiveness
$1,009,020Charles Garrison Fathman · Stanford University · P01 · FY2008 · AI
Understanding and Mimicking TCR Recognition with Therapeutic Monoclonal Antibodies.
$1,008,900David A Scheinberg · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$1,008,673Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Southwest EDRN Clinical Validation Center for Head and Neck Cancer
$1,008,620Karen Sue Anderson · Arizona State University-Tempe Campus · U01 · FY2025 · CA
Metapneumovirus Biology and Vaccine Development
$1,008,596Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI